Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 21, 2025; 31(23): 106261
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.106261
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.106261
Table 3 Postoperative clinical outcomes, n (%)
| ESD (n = 15) | STER (n = 10) | LWR (n = 25) | P value | |
| Follow up period, median (IQR) | 60.0 (26.5-66.5) | 24.0 (13.0-38.0) | 35.0 (21.0-60.0) | 0.065 |
| Tumor recurrence | 0 (0.0) | 0 (0.0) | 1 (4.0) | 0.600 |
| Death | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.000 |
- Citation: Lee AY, Lim SG, Cho JY, Kim S, Lee KM, Shin SJ, Noh CK, Lee GH, Hur H, Han SU, Son SY, Song JH. Comparison of treatment strategies for submucosal tumors originating from the muscularis propria at esophagogastric junction or cardia. World J Gastroenterol 2025; 31(23): 106261
- URL: https://www.wjgnet.com/1007-9327/full/v31/i23/106261.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i23.106261